Professor Dr. Sabrina Schreiner and Dr. Samuel Hofmann from the MHH Institute of Virology; Copyright: Karin Kaiser / MHH
Professor Dr. Sabrina Schreiner and Dr. Samuel Hofmann from the MHH Institute of Virology; Copyright: Karin Kaiser / MHH - Research team of the MHH and the Cluster of Excellence RESIST clarify cell mechanism. The result is the basis for new therapies. How do human cells defend themselves against adenoviruses? The team of RESIST Professor Dr. Sabrina Schreiner from the Institute of Virology at the Hannover Medical School (MHH) has come a good deal closer to answering this question. The team has elucidated an important defence mechanism and thus laid the foundation for the development of new treatment options. The research results, which were made possible through the RESIST Cluster of Excellence, were published in the scientific journal mbio. The two first authors are Lilian Göttig and Dr Christina Weiß from the Institute of Virology at the Technical University of Munich from Professor Schreiner's research group there. The team of authors also includes Dr Samuel Hofmann from the MHH Institute of Virology.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
